Navigation Links
Lilly Quality Leader Walsh Appointed to Company's Executive Committee

INDIANAPOLIS, July 1, 2011 /PRNewswire/ -- Fionnuala Walsh, Ph.D., will join the executive committee of Eli Lilly and Company (NYSE: LLY) on July 1.

Walsh will continue in her current role as Lilly's senior vice president of global quality, reporting to John Lechleiter, Ph.D., chairman, president, and CEO, and working to ensure Lilly continues to maintain high quality standards across its worldwide operations.

Walsh is a recognized thought leader in the quality industry, often speaking about Lilly's sustainable, integrated quality system and the company's commitment to maintaining a quality culture. Her presence on the company's most senior governance committee is expected to further underscore Lilly's ongoing commitment to quality.

A native of Ireland, Walsh earned a bachelor's degree and doctoral degree in chemistry from University College Dublin. She joined Lilly's Kinsale, Ireland, manufacturing site in 1988 as a technical services chemist. After numerous positions there, she moved into a role as global quality leader at the Lilly Corporate Center in Indianapolis in 2002.

In January 2003, Walsh was named executive director of quality for U.S. drug product and Lilly Technology Center operations. In July 2005, she was named vice president of global quality operations, and, in June 2007, she was named senior vice president of global quality.

About Eli Lilly and Company

Lilly, a leading, innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers—through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at C-LLY


SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
(Date:12/1/2015)... Assurex Health, Inc. today announced a ... providers an expanded range of options in helping ... depression, anxiety, bipolar disorder, posttraumatic stress disorder (PTSD), ... i .   --> i ... of two new drug classes, 17 FDA-approved medications ...
(Date:12/1/2015)... -- Six months of adjunctive metformin therapy does not improve glycemic ... new research from T1D Exchange and funded by ... effect on measures of obesity, including weight and BMI. The ... of the American Medical Association , are from the largest ... overweight and obese adolescents with type 1 diabetes. ...
(Date:12/1/2015)... , December 1, 2015 Russia ... III clinical trials. 70% of new drugs registered in Europe ... in Russia . --> Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... SAN ... today announced that the organization has awarded Education and Developmental Therapies (EDT), an ... Award. The award celebrates exceptional special needs providers that excel in synthesizing the ...
(Date:12/1/2015)... ... December 01, 2015 , ... TCS Healthcare Technologies ... and population health arenas, is pleased to announce that VIP Care Services, a ... successfully implemented the ACUITY Complete Care™ Management to back their collaborative catastrophic case ...
(Date:12/1/2015)... Viejo, CA (PRWEB) , ... December 01, 2015 , ... ... length of footage, and with full control over customization, the possibilities are truly endless, ... frame rate, position randomization, overlay depth position, vertical flip, horizontal flip, depth of field ...
(Date:12/1/2015)... Chicago, IL (PRWEB) , ... December 01, 2015 ... ... the Unified Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This ... sell, deploy and support Cisco Unified Contact Center solutions targeted to the high-end ...
(Date:11/30/2015)... (PRWEB) , ... December 01, 2015 , ... The Turks ... Journal, one of the leading digital news sites highlighting Caribbean destinations, has published five ... While much of North America shivers under chilly grey skies or worse, it's ...
Breaking Medicine News(10 mins):